← Evidence map

ArticleThoracic cancer2021

PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma.

Liyi ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33973394